Adi Mor
Patrimonio netto: 1 M $ in data 31/05/2026
Patrimonio netto: 1 M $ in data 31/05/2026
Adi Mor is the founder of Chemomab Therapeutics Ltd. since 2011, holding the title of CEO, Director & Chief Scientific Officer since 2023.
Dr. Mor was the founder of Chemomab Ltd. since 2011, holding the title of Director, Chief Executive & Scientific Officer from 2011 to 2021.
Dr. Mor holds a doctorate from Tel-Aviv University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/03/2026 | 10.346.160 ( 2,5% ) | 1 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Amministratore Delegato | 01/06/2023 |
| Società | Posizione | Fine |
|---|---|---|
Chemomab Ltd.
Chemomab Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops therapeutics for fibro-inflammatory diseases | Amministratore Delegato | 16/03/2021 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chemomab Ltd.
Chemomab Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops therapeutics for fibro-inflammatory diseases | Commercial Services |
Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale